Dyskeratosis congenita (DC) is an inherited bone marrow failure and cancer predisposition syndrome caused by defects in telomere biology. The most frequent solid tumors were head and neck squamous cell carcinomas followed by skin and anorectal cancer. The pediatric age group often present DC as a multisystem disorder. However, to date there has been no comprehensive quantitative analysis of cancer risk in Dyskeratosis Congenita. Since our patient is a case of malignancy, multimodality management is required which involves Radiation Oncology, Hematology, Medical oncology and Otorhinolaryngology. Proper counselling and multidisciplinary team approach is essential to treat a case of malignancy especially in Dyskeratosis congenita
Keywords: Circulating tumor cells; Liquid biopsy; Microfluidics Ovarian cancer; Cancer research; Tumor; Gonad cancer
Published Date: 2022-11-28; Received Date: 2022-11-01
